AMCP recently caught up with Todd Hood, senior director of national accounts at Spero Therapeutics, Inc., to learn about the company and gain insights on becoming an AMCP Corporate Member.
On Jan. 11, CMS released a proposed coverage decision that would cover the costs of monoclonal antibody treatments for Alzheimer's Disease patients only if they are enrolled in clinical trials.
On Jan. 6, CMS released a proposed rule that would require pharmacy price concessions be passed to patients at the point-of-sale and reinstate detailed MLR reporting requirements.
On Dec. 28, CMS released a proposed rule that would, in part, propose that adverse tiering is presumptively discriminatory and require that QHP issues offer more standardized plan options.
AMCP has recently published a manuscript in the Journal of Managed Care + Specialty Pharmacy (JMCP) focusing on the significant role that health plans, managed care organizations, prescribers, pharmacists, patients, and others have in decreasing the morbidity and mortality associated with opioid overdose.